Updated version 1 - PepsiCo will cut costs as weak North American business weighs on annual core profit outlook
路透社2026/10/08 10:26The third paragraph adds comments from the CEO, and the fourth paragraph provides information on stock price trends. Reuters, October 8 - PepsiCo (PEP.O) announced on Thursday that, due to weak snack and beverage demand in North America and rising input costs, it has lowered its annual core profit forecast and will further advance cost-cutting measures. Consumer goods manufacturers such as PepsiCo, General Mills (GIS.N), McCormick (MKC.N), and Conagra Brands (CAG.N) are facing a challenging operating environment: soaring raw material costs are squeezing profit margins, and rising gasoline prices are prompting consumers to be cautious with their spending, thereby dampening demand. “We are developing additional structural cost reduction measures, which will be implemented in the coming months to support investments aimed at accelerating organic revenue growth and mitigating the impact of input cost inflation,” CEO Ramon Laguarta stated in the announcement. The company’s shares rose about 1% in pre-market trading. The company expects that, after adjusting for currency fluctuations, fiscal 2026 core earnings per share will rise between 1% and 2%, lowered from the previous forecast of a 4% to 6% increase at the low end. In addition, the company expects annual organic revenue to grow by roughly 3%, compared to its previous forecast range of 2% to 4%. (For the convenience of non-English speakers, Reuters has automatically translated this report into several other languages. Automated translations may contain errors or may lack necessary context, and Reuters does not guarantee the accuracy of automated translation texts, which are provided for convenience only. Reuters accepts no liability for any damage or loss arising from the use of the automated translation feature.)
Added CEO comments in paragraph 3 and stock price movement in paragraph 4.
Reuters, October 8 - PepsiCo (PEP.O) said on Thursday that, due to weak demand for snacks and beverages in North America and rising input costs, it has lowered its annual core profit forecast and will further implement cost-cutting measures.
Consumer goods manufacturers such as PepsiCo, General Mills GIS.N, McCormick MKC.N and Conagra Brands CAG.N are facing challenging operating conditions: surging raw material costs are squeezing profit margins, while rising gasoline prices are making consumers more cautious, thereby dampening demand.
"We are formulating further structural cost reduction measures which will be implemented in the coming months to support investments aimed at accelerating organic revenue growth and mitigating the impact of input cost inflation," CEO Ramon Laguarta said in a statement.
The company's shares rose about 1% in pre-market trading.
The company expects core earnings per share, adjusted for currency fluctuations, to grow by 1% to 2% in fiscal year 2026, compared to a previous forecast of growth at the lower end of the 4% to 6% range.
In addition, the company expects annual organic revenue to grow by about 3%, compared to a prior forecast in the 2% to 4% range.
(To assist non-English speakers, Reuters has automatically translated its reporting into several other languages. Since automated translation may contain errors or lack context, Reuters does not guarantee the accuracy of the automated translation and provides it for readers' convenience only. Reuters accepts no responsibility for any damage or loss caused by the use of automated translation functions.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Kepler Weber executives trim stake by R$ 24,461.40 via on-market sales
Kepler Weber disclosed two cash equity sales by management totaling 3,788 shares for R$ 24,461.40 at an average R$ 6.45674. Transactions were executed via XP, with sales on day 1 at R$ 6.55 and day 16 at R$ 6.41. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kepler Weber SA published the original content used to generate this news brief on October 08, 2026, and is solely responsible for the information contained therein.
BUZZ - Universal Display shares fall after Citi downgraded rating
On October 8, shares of OLED materials company Universal Display (OLED.O) fell by 4.5% in pre-market trading to $73.8. Citigroup downgraded Universal Display from “Neutral” to “Sell” and lowered its price target from $85 to $71. The new target price implies about an 8% downside from the previous closing price. The brokerage pointed out the continued weakness in the smartphone market and delays in the adoption of blue OLED technology. Citigroup also noted that high memory costs and weak demand for mid- and low-end smartphones may continue to drag down sales of OLED materials. Out of 10 brokerages, seven rate the stock as “Buy” or higher, and three rate it as “Hold.” The median price target is $117.5. As of the previous trading day's close, the stock had fallen a cumulative 33.88% so far this year.
ICON schedules third-quarter earnings conference call
ICON will report third-quarter 2026 results on Tuesday, Oct. 27, 2026, following the market close. Management will discuss the results on an earnings call, webcast Wednesday, Oct. 28, 2026, at 8:00 a.m. ET. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ICON plc published the original content used to generate this news brief via Business Wire (Ref. ID: 202610080800BIZWIRE_USPR_____20261008_BW018649) on October 08, 2026, and is solely responsible for the information contained therein.
BUZZ-Atrium Therapeutics shares surge after completing $50 million equity financing
On October 8, shares of heart disease drug developer Atrium Therapeutics (RNA.O) rose 11.3% to $8.83 in pre-market trading on Thursday after the company successfully raised $50 million. The biopharmaceutical company announced it has agreed to sell about 6.3 million shares and pre-funded warrants to institutional investors through a private placement at $7.93 per share. RNA’s shares closed down 0.8% at $7.93 on Wednesday and have fallen roughly 44% in the past month. The company plans to use the net proceeds for the development of its two main product candidates, other research projects, among other uses. Atrium expects that the funds raised, together with existing cash and investments, will be sufficient to support its operations through 2028. Leerink acted as the lead placement agent for this offering, with Cantor Fitzgerald, Barclays, and Wells Fargo participating as well. Based in San Diego, California, Atrium has signed collaboration agreements with Bristol Myers Squibb (BMY.N) and Eli Lilly (LLY.N), and has about 17.1 million shares outstanding. Atrium began public trading on February 27 (link), following a spinoff from Avidity Biosciences (link), which was subsequently acquired by Swiss pharmaceutical company Novartis (NOVN.S).
Crypto prices
More
